Compile Data Set for Download or QSAR
maximum 50k data
Found 12 Enz. Inhib. hit(s) with all data for entry = 9595
TargetReplicase polyprotein 1ab(HCoV-229E)
Atea Pharmaceuticals

US Patent
LigandPNGBDBM476337(US10874687, Compound 1A)
Affinity DataEC50:  1.60E+3nMAssay Description:Compound activity against coronavirus was based on inhibition of virus induced cytopathogenicity acutely infected with a multiplicity of infection (m...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetReplicase polyprotein 1ab(HCoV-229E)
Atea Pharmaceuticals

US Patent
LigandPNGBDBM476338(US10874687, Compound 1B)
Affinity DataEC50:  2.50E+3nMAssay Description:Compound activity against coronavirus was based on inhibition of virus induced cytopathogenicity acutely infected with a multiplicity of infection (m...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetReplicase polyprotein 1ab(HCoV-229E)
Atea Pharmaceuticals

US Patent
LigandPNGBDBM476339(US10874687, Sofosbuvir)
Affinity DataEC50: >1.00E+5nMAssay Description:Compound activity against coronavirus was based on inhibition of virus induced cytopathogenicity acutely infected with a multiplicity of infection (m...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetReplicase polyprotein 1ab(HCoV-229E)
Atea Pharmaceuticals

US Patent
LigandPNGBDBM476337(US10874687, Compound 1A)
Affinity DataEC50:  2.00E+3nMAssay Description:Compound activity against coronavirus was based on inhibition of virus induced cytopathogenicity acutely infected with a multiplicity of infection (m...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetReplicase polyprotein 1ab(HCoV-229E)
Atea Pharmaceuticals

US Patent
LigandPNGBDBM476338(US10874687, Compound 1B)
Affinity DataEC50:  2.90E+3nMAssay Description:Compound activity against coronavirus was based on inhibition of virus induced cytopathogenicity acutely infected with a multiplicity of infection (m...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetReplicase polyprotein 1ab(HCoV-OC43)
Atea Pharmaceuticals

US Patent
LigandPNGBDBM476339(US10874687, Sofosbuvir)
Affinity DataEC50: >1.00E+5nMAssay Description:Compound activity against coronavirus was based on inhibition of virus induced cytopathogenicity acutely infected with a multiplicity of infection (m...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetReplicase polyprotein 1ab(HCoV-OC43)
Atea Pharmaceuticals

US Patent
LigandPNGBDBM476337(US10874687, Compound 1A)
Affinity DataEC50:  1.60E+3nMAssay Description:Compound activity against coronavirus was based on inhibition of virus induced cytopathogenicity acutely infected with a multiplicity of infection (m...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetReplicase polyprotein 1ab(HCoV-OC43)
Atea Pharmaceuticals

US Patent
LigandPNGBDBM476338(US10874687, Compound 1B)
Affinity DataEC50:  2.00E+3nMAssay Description:Compound activity against coronavirus was based on inhibition of virus induced cytopathogenicity acutely infected with a multiplicity of infection (m...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetReplicase polyprotein 1ab(HCoV-OC43)
Atea Pharmaceuticals

US Patent
LigandPNGBDBM476339(US10874687, Sofosbuvir)
Affinity DataEC50: >1.00E+5nMAssay Description:Compound activity against coronavirus was based on inhibition of virus induced cytopathogenicity acutely infected with a multiplicity of infection (m...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetReplicase polyprotein 1ab(HCoV-OC43)
Atea Pharmaceuticals

US Patent
LigandPNGBDBM476337(US10874687, Compound 1A)
Affinity DataEC50:  2.00E+3nMAssay Description:Compound activity against coronavirus was based on inhibition of virus induced cytopathogenicity acutely infected with a multiplicity of infection (m...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetReplicase polyprotein 1ab(HCoV-OC43)
Atea Pharmaceuticals

US Patent
LigandPNGBDBM476338(US10874687, Compound 1B)
Affinity DataEC50:  2.20E+3nMAssay Description:Compound activity against coronavirus was based on inhibition of virus induced cytopathogenicity acutely infected with a multiplicity of infection (m...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetReplicase polyprotein 1ab(HCoV-229E)
Atea Pharmaceuticals

US Patent
LigandPNGBDBM476339(US10874687, Sofosbuvir)
Affinity DataEC50: >1.00E+5nMAssay Description:Compound activity against coronavirus was based on inhibition of virus induced cytopathogenicity acutely infected with a multiplicity of infection (m...More data for this Ligand-Target Pair
In DepthDetails US Patent